Cargando…
The evolving treatment paradigm of lung cancer in China
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069462/ https://www.ncbi.nlm.nih.gov/pubmed/35530151 http://dx.doi.org/10.1016/j.apsb.2022.01.010 |
_version_ | 1784700436022820864 |
---|---|
author | Xie, Wei Liu, Shuanghuan Li, Guanqiao Xu, Huiyan Zhou, Liyun |
author_facet | Xie, Wei Liu, Shuanghuan Li, Guanqiao Xu, Huiyan Zhou, Liyun |
author_sort | Xie, Wei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9069462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90694622022-05-05 The evolving treatment paradigm of lung cancer in China Xie, Wei Liu, Shuanghuan Li, Guanqiao Xu, Huiyan Zhou, Liyun Acta Pharm Sin B News Elsevier 2022-03 2022-01-29 /pmc/articles/PMC9069462/ /pubmed/35530151 http://dx.doi.org/10.1016/j.apsb.2022.01.010 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | News Xie, Wei Liu, Shuanghuan Li, Guanqiao Xu, Huiyan Zhou, Liyun The evolving treatment paradigm of lung cancer in China |
title | The evolving treatment paradigm of lung cancer in China |
title_full | The evolving treatment paradigm of lung cancer in China |
title_fullStr | The evolving treatment paradigm of lung cancer in China |
title_full_unstemmed | The evolving treatment paradigm of lung cancer in China |
title_short | The evolving treatment paradigm of lung cancer in China |
title_sort | evolving treatment paradigm of lung cancer in china |
topic | News |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069462/ https://www.ncbi.nlm.nih.gov/pubmed/35530151 http://dx.doi.org/10.1016/j.apsb.2022.01.010 |
work_keys_str_mv | AT xiewei theevolvingtreatmentparadigmoflungcancerinchina AT liushuanghuan theevolvingtreatmentparadigmoflungcancerinchina AT liguanqiao theevolvingtreatmentparadigmoflungcancerinchina AT xuhuiyan theevolvingtreatmentparadigmoflungcancerinchina AT zhouliyun theevolvingtreatmentparadigmoflungcancerinchina AT xiewei evolvingtreatmentparadigmoflungcancerinchina AT liushuanghuan evolvingtreatmentparadigmoflungcancerinchina AT liguanqiao evolvingtreatmentparadigmoflungcancerinchina AT xuhuiyan evolvingtreatmentparadigmoflungcancerinchina AT zhouliyun evolvingtreatmentparadigmoflungcancerinchina |